Business
Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units
(TheNewswire) Calgary, Alberta – TheNewswire - August 12, 2021...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Calgary, Alberta –\n \n \n TheNewswire -\n \n \n August 12, 2021\n \n \n –\n \n \n Voyageur Pharmaceuticals\nLtd.\n \n \n (\n \n \n TSXV\n \n \n :\n \n \n VM\n \n \n )\n \n \n USA\n \n \n (OTC\n \n \n :\n \n \n \n VYYRF)\n \n \n \n (the \"Company\"\nor \"Voyageur\")\n \n \n announced that it has\nissued 200,000 options to directors pursuant to its incentive stock\noption plan (the “Options”). In addition, the Company announces it\nhas issued 169,872 Deferred Share Units (“DSU’S”) to directors\npursuant to its equity incentive compensation plan.\n \n \n \n \n The grants referred to above are subject to approval of\nthe TSX Venture Exchange (\"TSXV\").  The Company’s equity\nincentive compensation plan was adopted by the Company following\nreceipt of approval by a majority of disinterested shareholders at the\nCompany’s AGM held on June 23, 2021.  The incentive stock option\nplan of the Company was also approved at this meeting.\n \n \n \n \n About Voyageur\n \n \n \n \n Voyageur Pharmaceuticals Ltd. is Canadian public\ncompany listed on the TSXV under the trading symbol VM. Voyageur is\nfocused on the development of barite and iodine, Active Pharmaceutical\nIngredient (API) minerals. The near-term focus is developing barium\nand iodine radio-contrast pharmaceutical products.  Voyageur’s goal\nis to initially generate the positive cash flow from operations using\nthird party GMP pharmaceutical manufacturers in Canada and\ninternationally. Ultimately, Voyageur has plans to build all the\nrequired infrastructure to become 100% self-sufficient with all\nmanufacturing. Voyageur owns a 100% interest in three barium sulfate\n(barite) projects including two properties suitable in grade for the\nindustrial barite marketplace, with interests in a high-grade iodine,\nlithium & bromine brine project located in Utah, USA.\n \n \n \n \n Voyageur is moving forward with its business plan of\nbecoming the only fully-integrated company in the radiology medical\nfield, by controlling all primary input costs under the motto\nof:\n \n \n \"From the Earth to the Bottle\"\n \n \n \n \n For Further Media Information or to\nset up...